Skip to main content

dari

|

Scientists at The Wistar Institute Discover Novel Series of SARS-CoV-2 Mpro Inhibitors for Potential New COVID-19 Treatments

PHILADELPHIA — (Oct. 8, 2024) — New research from The Wistar Institute’s Salvino lab — led by professor Joseph Salvino, Ph.D. — has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, acco…
Read more
|

The Wistar Institute and University of Pennsylvania Scientists Identify Potential Target Gene within Certain HIV Reservoir Cells

Drs. Lieberman, Collman, and Co-Authors Link RSAD2/Viperin Gene with Certain Chronically HIV-Infected Cells
Read more
|

Wistar Institute Researchers Identify Parkinson-related Protein’s Role in Cancer and T Cell Activation

PHILADELPHIA — (September 17th, 2024) — The Wistar Institute’s President and CEO, Dario C. Altieri, M.D., and team have demonstrated the role of Parkin — a protein implicated in Parkinson’s disease — in the body’s innate immune response to cancer. P…
Read more
|

The Wistar Institute Celebrates Ten Years of The Robert and Penny Fox Tower

On September 14th, 2014, The Robert and Penny Fox Tower at The Wistar Institute was opened, marking a monumental change in the look and biomedical research capacity of the Institute. This September, we celebrate 10 years of the Fox Tower made possib…
Read more
|

The Wistar Institute Launches HIV Cure and Viral Diseases Center

The Wistar Institute — building on its history of leading advances in human health as the nation’s first nonprofit biomedical research institute — is creating a new HIV Cure and Viral Diseases Center, made possible by a $24 million institutional inv…
Read more